Everence Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Buy
+7,429
New +$488K 0.03% 430
2026
Q1
Sell
-18,516
Closed -$1.52M 834
2025
Q4
$1.52M Hold
18,516
0.09% 180
2025
Q3
$1.39M Buy
18,516
+8,606
+87% +$642K 0.08% 186
2025
Q2
$734K Sell
9,910
-2,980
-23% -$207K 0.05% 281
2025
Q1
$1.04M Sell
12,890
-5,980
-32% -$514K 0.07% 224
2024
Q4
$1.48M Buy
18,870
+10,220
+118% +$869K 0.1% 171
2024
Q3
$812K Hold
8,650
0.05% 284
2024
Q2
$659K Hold
8,650
0.05% 309
2024
Q1
$786K Hold
8,650
0.05% 278
2023
Q4
$669K Hold
8,650
0.05% 315
2023
Q3
$589K Buy
8,650
+4,410
+104% +$321K 0.05% 333
2023
Q2
$337K Hold
4,240
0.03% 484
2023
Q1
$348K Buy
+4,240
New +$303K 0.03% 481

Other funds holding GEHC

Everence Capital Management's GEHC Position: Q2 2026 in Review

Everence Capital Management opened a new position in GE HealthCare (GEHC) in Q2 2026: 7,429 shares worth $476K. The stake represents 0.03% of the portfolio and ranks #430 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in GEHC as recently as Q4 2025.

Everence Capital Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.52M in Q4 2025. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Everence Capital Management held 7,429 shares of GE HealthCare worth $476K as of Q2 2026.
  • GE HealthCare was a new Everence Capital Management position in Q2 2026.
  • GE HealthCare made up 0.03% of Everence Capital Management's portfolio in Q2 2026, its #430 holding.
  • Everence Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Everence Capital Management's GE HealthCare position peaked at $1.52M in Q4 2025.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.